[Topical application of the controlled release strips containing ofloxacin (PT-01) in periodontal therapy]. 1988

H Okada, and S Kimura, and I Ishikawa, and S Hagiwara, and H Hasegawa, and M Kobayashi, and A Yamaoka, and M Ueda, and M Aono, and K Maeda

The association of periodontopathic bacteria in the subgingival plaque with human periodontal disease has been well established. However, past attempts at reducing the level of pathogenic bacteria by using antibiotics as well as other antibacterial substance, so far, have not been fully successful. In this study, the effect of topical application of ofloxacin (OFLX), a synthetic antibiotic, was evaluated in relation to the clinical parameters. For this purpose, the new developed controlled release strips containing OFLX (PT-01), in which there were structurally immediate- and sustained-releasing portions, were used. 147 adult patients suffering from moderate to severe periodontitis were selected for this study. The patients had received no periodontal treatment previously and had taken no antibiotics within the preceding 6 months. Three different sites with a deep probing pocket depth (greater than or equal to 5 mm) were randomly selected in each patient, and were divided into three groups, i.e., PT-01 applied site (T), placebo-applied site (P) and control site (C). Periodontal treatments consisted of oral hygiene instruction and supragingival scaling on day 0 and 7, and subgingival scaling and root planing on day 14. PT-01 was applied in the periodontal pocket weekly on day 0 to 35, and clinical parameters on each site were recorded weekly. The results showed that, during first 14 days, significant reduction in the percentage of the sites which showed bleeding on probing, pus discharge or mobility of the tooth was observed in the PT-01 applied site. However in placebo and/or control group, no significant change in any parameters was observed in this period. While, after subgingival scaling and root planing, significant improvement was found at all sites in every clinical parameter. Especially, PT-01 applied sites showed significant improvement in the gingival index and bleeding on probing, compared to placebo-applied or control sites. These results suggest that weekly insertion of PT-01 in the periodontal pocket along with the subgingival scaling and root planing could have significant effect on the improvements in the gingival inflammation. Taken together, weekly application of PT-01 might have ameliorating effect as adjuncts of mechanical subgingival plaque control in the periodontal treatment.

UI MeSH Term Description Entries
D010518 Periodontitis Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology) Pericementitis,Pericementitides,Periodontitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D015242 Ofloxacin A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. DL-8280,DR-3355,Hoe-280,ORF-28489,Ofloxacin Hydrochloride,Ofloxacine,Ru-43280,Tarivid,DL 8280,DL8280,DR 3355,DR3355,Hoe 280,Hoe280,ORF 28489,ORF28489,Ru 43280,Ru43280

Related Publications

H Okada, and S Kimura, and I Ishikawa, and S Hagiwara, and H Hasegawa, and M Kobayashi, and A Yamaoka, and M Ueda, and M Aono, and K Maeda
March 1989, Nihon Shishubyo Gakkai kaishi,
H Okada, and S Kimura, and I Ishikawa, and S Hagiwara, and H Hasegawa, and M Kobayashi, and A Yamaoka, and M Ueda, and M Aono, and K Maeda
March 1989, Nihon Shishubyo Gakkai kaishi,
H Okada, and S Kimura, and I Ishikawa, and S Hagiwara, and H Hasegawa, and M Kobayashi, and A Yamaoka, and M Ueda, and M Aono, and K Maeda
January 1992, Journal of periodontology,
H Okada, and S Kimura, and I Ishikawa, and S Hagiwara, and H Hasegawa, and M Kobayashi, and A Yamaoka, and M Ueda, and M Aono, and K Maeda
March 1989, Nihon Shishubyo Gakkai kaishi,
H Okada, and S Kimura, and I Ishikawa, and S Hagiwara, and H Hasegawa, and M Kobayashi, and A Yamaoka, and M Ueda, and M Aono, and K Maeda
June 1989, Hiroshima Daigaku shigaku zasshi. The Journal of Hiroshima University Dental Society,
H Okada, and S Kimura, and I Ishikawa, and S Hagiwara, and H Hasegawa, and M Kobayashi, and A Yamaoka, and M Ueda, and M Aono, and K Maeda
December 1989, Nihon Shishubyo Gakkai kaishi,
H Okada, and S Kimura, and I Ishikawa, and S Hagiwara, and H Hasegawa, and M Kobayashi, and A Yamaoka, and M Ueda, and M Aono, and K Maeda
February 1991, Dentistry today,
H Okada, and S Kimura, and I Ishikawa, and S Hagiwara, and H Hasegawa, and M Kobayashi, and A Yamaoka, and M Ueda, and M Aono, and K Maeda
January 2005, Vojnosanitetski pregled,
H Okada, and S Kimura, and I Ishikawa, and S Hagiwara, and H Hasegawa, and M Kobayashi, and A Yamaoka, and M Ueda, and M Aono, and K Maeda
October 2000, Biological & pharmaceutical bulletin,
H Okada, and S Kimura, and I Ishikawa, and S Hagiwara, and H Hasegawa, and M Kobayashi, and A Yamaoka, and M Ueda, and M Aono, and K Maeda
May 1992, Cornea,
Copied contents to your clipboard!